An Expanded Genetic Code Enables Trimethylamine Metabolism in Human Gut Bacteria
ABSTRACT Cardiovascular disease (CVD) has been linked to animal-based diets, which are a major source of trimethylamine (TMA), a precursor of the proatherogenic compound trimethylamine-N-oxide (TMAO). Human gut bacteria in the genus Bilophila have genomic signatures for genetic code expansion that c...
Guardado en:
Autores principales: | Veronika Kivenson, Stephen J. Giovannoni |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e4d1b08171ab4967809b0f58e4d5e149 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genomic Insights into Adaptations of Trimethylamine-Utilizing Methanogens to Diverse Habitats, Including the Human Gut
por: Jacobo de la Cuesta-Zuluaga, et al.
Publicado: (2021) -
Editorial: Lactic Acid Bacteria: Microbial Metabolism and Expanding Applications
por: Jian-Ming Liu, et al.
Publicado: (2021) -
Investigative genetics
Publicado: (2010) -
Interindividual Variation in Dietary Carbohydrate Metabolism by Gut Bacteria Revealed with Droplet Microfluidic Culture
por: Max M. Villa, et al.
Publicado: (2020) -
Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
por: BingYu Wang, et al.
Publicado: (2021)